COVID-19 Archives - DelveInsight

COVID-19

pharma-news-and-updates-for-Ascendis-MicroTransponder-BioMarin-Zimmer-Biomet-Canary-Medical
Ascendis’s SKYTROFA; MicroTransponder’s VNS System (Vivistim); BioMarin’s Voxzogo; Zi...

FDA's Green Flag to Ascendis's Once-Weekly SKYTROFA for Treatment of Pediatric Growth Hormone DeficiencyFor the treatment of growth failure due to deficiency of growth hormones, the USFDA appr...


Coronavirus-covid-19-vaccine-landscape
Charting out the COVID-19 Vaccine Landscape

The uncontrolled outbreaks of Covid-19 have brought unprecedented challenges to the world community. It has created an imbalance in mental, social, and economic well-being. Apart from this, it has...


pharma-news-updates-for-amgen-verrica-nexturn-rosvivo-fennec
Amgen a leader in Undruggable Lung Cancer; Verrica’s Skin Disease Drug Delays; Fennec̵...

FDA Validates Use of Amgen’s KRAS Inhibitor in Lung Cancer In a pathbreaking move, Amgen has gone ahead to emerge as a trailblazer in the undruggable lung cancer space with the approval o...


COVID-19-Vaccines-Hemophilia-B-uniQure-Gene-Therapy-J-J-Covid-Vaccine-Covaxin
Ocugen-Bharat Biotech’s Covaxin Against B.1.617 Corona Variant; uniQure Shares; J&J Covid V...

Ocugen-Bharat Biotech’s Covaxin Shows Efficacy Against B.1.617 VariantWith the COVID-19 cases exponentially increasing, there is a worrisome climate all over the world. Physicians, doctors, re...


Merck, Gilead teams up for HIV treatment; Bright Future for Sanofi/Regeneron’s Libtayo; Roche acquires GenMark; FDA okays Melinta’s Kimyrsa
Merck, Gilead teams up for HIV treatment; Bright Future for Sanofi/Regeneron’s Libtayo; Roche ac...

Merck, Gilead  to co-develop combined HIV treatmentsMerck and Gilead have announced a collaboration to investigate Gilead’s investigational capsid inhibitor, lenacapavir, and Merck’s inve...


Aurinia's Lupkynis for Lupus; Toripalimab; Merck’s Covid-19 Vaccines fail
Aurinia’s Lupkynis for Lupus; FDA Fast Track Designation for Toripalimab; Wren Therapeutics...

Hot on the heels, Aurinia launches its drug in the Lupus market after GSKAurinia Pharmaceuticals has recently got the USFDA approval for its Lupkynis (voclosporin) in combination with a backgr...


Anxiety and COVID-19
We’re all in this together!

Overcoming Anxiety in the pandemic times!!The past year has been a tough journey for all of us. It has taught us many lessons that are going to stay with us for the whole of our lives. Thus, D...


Historic win for Pfizer's COVID-19 Vaccine; Alexion Buyout; and more
FTA for Gannex’s ASC4; Disappointment for Incyte’s Ruxolitinib; Historic win for Pfizer, BioNTech...

Gannex received US FDA fast track designation for its NASH drug, ASC42 an FXR AgonistGannex Pharma has received Fast Track designation approval from FDA for its drug candidate ASC42 for non-al...


recent-pharma-news-and-updates-for-gilead-novartis-lilly-innovent
Novartis’ COVID-19 deal; Shattered hopes for Remdesivir; Lilly’s R&D pact with ...

Novartis bags Mesoblast's cell therapy, Remestemcel-L for COVID-19 ARDSThe COVID-19 pandemic has put tremendous pressure on scientists to develop a safe and effective vaccine as early as possi...


pharma-news-for-roche-prestige-covid-19
Venclexta full approval; PBP1510 Orphan Status; Roche/ Genesis collab; Immunomodulators for COVID-19

Full FDA Approval for Venclexta Combinations for Acute Myeloid LeukemiaThe US FDA has granted its full approval to Venclexta (venetoclax) for newly diagnosed acute myeloid leukemia (AML) in ...


Editor's Pick
Discover How Learning Disability Treatment Landscape is Evolving with the Eme...

A Learning Disability (LD) is a neurological condition resulting from genetic and neuro...

Development of Gene Therapies in Dermatology

What is Gene Therapy and Is the Skin Suitable for Gene Therapy? Since its first discove...

Mapping the Increasing Burden of Heart Failure: What Does it Bring for Health...

Heart failure (HF), also referred to as Congestive Heart failure (CHF), is a condition ...

Bone Metastasis Market: A Debilitating Consequence for Many Tumors

In advanced cancer patients, the most common site for the occurrence of metastasis is c...

Evaluating the Role of Digital Therapeutics as an Alternative to Conventional...

Depression is a mental condition characterized by prolonged series of poor moods, loss ...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.